<?xml version="1.0" encoding="UTF-8"?>
 <rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:cc="http://web.resource.org/cc/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/" xmlns:admin="http://webns.net/mvcb/">
  <channel rdf:about="http://pinboard.in">
    <title>Pinboard (Herbelizer)</title>
    <link>https://pinboard.in/u:Herbelizer/public/</link>
    <description>recent bookmarks from Herbelizer</description>
    <items>
      <rdf:Seq>	<rdf:li rdf:resource="http://www.aerztezeitung.de/news/article/804966/twitter-facebook-visier-pharmaindustrie.html"/>
	<rdf:li rdf:resource="http://www.medien-doktor.de/sprechstunde/medizinberichterstattung-die-rolle-der-pressemitteilungen/"/>
	<rdf:li rdf:resource="http://thehealthcareblog.com/blog/2012/01/12/health-care-social-media-%e2%80%93-how-to-engage-online-without-getting-into-trouble-part-i/"/>
	<rdf:li rdf:resource="http://blogs.wsj.com/health/2012/01/09/fda-has-some-social-media-advice-for-pharma/?mod=WSJBlog"/>
	<rdf:li rdf:resource="http://www.fiercebiotechit.com/story/10-social-media-lessons-pharma/2012-01-04"/>
	<rdf:li rdf:resource="http://www.slate.com/blogs/future_tense/2012/01/03/big_pharma_and_social_media_fda_releases_draft_guidelines_.html"/>
	<rdf:li rdf:resource="http://adage.com/article/digital/fda-s-social-media-guidelines-befuddle-big-pharma/231855/"/>
	<rdf:li rdf:resource="https://www.cegedimstrategicdata.com/Press/Documents/CSD_RanksPharmaSocialMediaPresence.pdf"/>
	<rdf:li rdf:resource="http://www.indiskretionehrensache.de/2011/11/merck-vs-facebook/"/>
	<rdf:li rdf:resource="http://www.businessinsider.com/heres-the-cure-for-social-media-headaches-2011-9"/>
	<rdf:li rdf:resource="http://www.pharmalot.com/2011/09/using-social-media-to-report-side-effects"/>
	<rdf:li rdf:resource="http://www.inpharm.com/news/166802/digital-pharma-social-media-twitter-abpi-code"/>
	<rdf:li rdf:resource="http://www.facebookbiz.de/artikel/pharmakonzerne-fluchten-vor-geoffneten-facebook-pinnwanden"/>
	<rdf:li rdf:resource="http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Novartis-Kundenfang-mit-fiktiven-Biografien-/story/12484176"/>
      </rdf:Seq>
    </items>
  </channel><item rdf:about="http://www.aerztezeitung.de/news/article/804966/twitter-facebook-visier-pharmaindustrie.html">
    <title>Twitter und Facebook im Visier der Pharmaindustrie</title>
    <dc:date>2012-02-18T08:10:40+00:00</dc:date>
    <link>http://www.aerztezeitung.de/news/article/804966/twitter-facebook-visier-pharmaindustrie.html</link>
    <dc:creator>Herbelizer</dc:creator><dc:subject>Pharmaindustrie SocialMedia</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:900f9ed89a23/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.medien-doktor.de/sprechstunde/medizinberichterstattung-die-rolle-der-pressemitteilungen/">
    <title>Medizinberichterstattung: Die Rolle der Pressemitteilungen | medien-doktor.de</title>
    <dc:date>2012-02-16T19:21:38+00:00</dc:date>
    <link>http://www.medien-doktor.de/sprechstunde/medizinberichterstattung-die-rolle-der-pressemitteilungen/</link>
    <dc:creator>Herbelizer</dc:creator><description><![CDATA["Die Qualität der Pressemitteilungen scheint die Qualität der journalistischen Artikel zu beeinflussen. Und zwar im Guten wie im Schlechten. Gute Pressemitteilungen führten zu guten Presseartikeln, während schlechte Pressemitteilungen zu eher schlechten Artikel führten."]]></description>
<dc:subject>Medizin Pharma Pharmaindustrie PR</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:7b9492ab2bf3/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Medizin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:PR"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://thehealthcareblog.com/blog/2012/01/12/health-care-social-media-%e2%80%93-how-to-engage-online-without-getting-into-trouble-part-i/">
    <title>Health Care Social Media – How to Engage Online Without Getting into Trouble (Part II) | The Health Care Blog</title>
    <dc:date>2012-01-13T07:01:51+00:00</dc:date>
    <link>http://thehealthcareblog.com/blog/2012/01/12/health-care-social-media-%e2%80%93-how-to-engage-online-without-getting-into-trouble-part-i/</link>
    <dc:creator>Herbelizer</dc:creator><dc:subject>SocialMedia Pharmaindustrie</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:c236e1cc18ea/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://blogs.wsj.com/health/2012/01/09/fda-has-some-social-media-advice-for-pharma/?mod=WSJBlog">
    <title>FDA Has (Some) Social Media Advice For Pharma - Health Blog - WSJ</title>
    <dc:date>2012-01-10T06:16:44+00:00</dc:date>
    <link>http://blogs.wsj.com/health/2012/01/09/fda-has-some-social-media-advice-for-pharma/?mod=WSJBlog</link>
    <dc:creator>Herbelizer</dc:creator><dc:subject>SocialMedia Pharmaindustrie</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:7dff812c725e/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.fiercebiotechit.com/story/10-social-media-lessons-pharma/2012-01-04">
    <title>10 social media lessons for pharma - FierceBiotechIT</title>
    <dc:date>2012-01-05T12:48:53+00:00</dc:date>
    <link>http://www.fiercebiotechit.com/story/10-social-media-lessons-pharma/2012-01-04</link>
    <dc:creator>Herbelizer</dc:creator><description><![CDATA["But the giant regulatory bugaboo, not only of social media but of regulated speech writ large, is off-label communications."
]]></description>
<dc:subject>SocialMedia Pharmaindustrie</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:c435fcc67fc7/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.slate.com/blogs/future_tense/2012/01/03/big_pharma_and_social_media_fda_releases_draft_guidelines_.html">
    <title>Big Pharma and social media: FDA releases draft guidelines.</title>
    <dc:date>2012-01-04T06:17:43+00:00</dc:date>
    <link>http://www.slate.com/blogs/future_tense/2012/01/03/big_pharma_and_social_media_fda_releases_draft_guidelines_.html</link>
    <dc:creator>Herbelizer</dc:creator><description><![CDATA["Unfortunately, the draft guidelines finally released last week by the Food and Drug Administration won’t clear up too much of the confusion. The 15-page document (PDF)—and it’s important to emphasize that this is still only a draft—focuses  exclusively on social media discussion of off-label medication use."]]></description>
<dc:subject>SocialMedia Pharmaindustrie</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:009036f274d7/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://adage.com/article/digital/fda-s-social-media-guidelines-befuddle-big-pharma/231855/">
    <title>FDA's Social-Media 'Guidelines' Befuddle Big Pharma | Digital - Advertising Age</title>
    <dc:date>2012-01-04T06:16:58+00:00</dc:date>
    <link>http://adage.com/article/digital/fda-s-social-media-guidelines-befuddle-big-pharma/231855/</link>
    <dc:creator>Herbelizer</dc:creator><description><![CDATA["The 15-page FDA guidance addresses only off-label information, laying out instructions for pharma companies on how to respond to consumers seeking information for a prescription drug other than what it is indicated for. That is, in a very rudimentary example, if a consumer asked a question on Facebook or called a pharma company's 800 number asking whether it was safe for men over the age of 50 to use Botox, a representative for Botox-maker Allergan could certainly answer the question."]]></description>
<dc:subject>SocialMedia Pharmaindustrie</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:f4e4947fb2eb/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.cegedimstrategicdata.com/Press/Documents/CSD_RanksPharmaSocialMediaPresence.pdf">
    <title>CSD_RanksPharmaSocialMediaPresence.pdf (application/pdf Object)</title>
    <dc:date>2011-12-28T12:19:29+00:00</dc:date>
    <link>https://www.cegedimstrategicdata.com/Press/Documents/CSD_RanksPharmaSocialMediaPresence.pdf</link>
    <dc:creator>Herbelizer</dc:creator><dc:subject>Pharmaindustrie SocialMedia</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:cceb0b51ab78/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.indiskretionehrensache.de/2011/11/merck-vs-facebook/">
    <title>Shitstorm Warnung: Merck vs. Facebook (und was Facebook lernen muss)</title>
    <dc:date>2011-11-29T16:58:15+00:00</dc:date>
    <link>http://www.indiskretionehrensache.de/2011/11/merck-vs-facebook/</link>
    <dc:creator>Herbelizer</dc:creator><dc:subject>SocialMedia Pharmaindustrie Facebook Shitstorm</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:a48666b06a59/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Facebook"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Shitstorm"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.businessinsider.com/heres-the-cure-for-social-media-headaches-2011-9">
    <title>Here's the Cure for Social Media Headaches</title>
    <dc:date>2011-09-20T18:42:19+00:00</dc:date>
    <link>http://www.businessinsider.com/heres-the-cure-for-social-media-headaches-2011-9</link>
    <dc:creator>Herbelizer</dc:creator><dc:subject>SocialMedia Pharmaindustrie</dc:subject>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:f1c857101760/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.pharmalot.com/2011/09/using-social-media-to-report-side-effects">
    <title>Using Social Media To Report Side Effects? // Pharmalot</title>
    <dc:date>2011-09-20T18:40:54+00:00</dc:date>
    <link>http://www.pharmalot.com/2011/09/using-social-media-to-report-side-effects</link>
    <dc:creator>Herbelizer</dc:creator><dc:subject>SocialMedia Pharmaindustrie</dc:subject>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:5a5c2de76e5c/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.inpharm.com/news/166802/digital-pharma-social-media-twitter-abpi-code">
    <title>Digital Pharma: Twitter slip-up shouldn't silence pharma | InPharm</title>
    <dc:date>2011-09-11T15:27:59+00:00</dc:date>
    <link>http://www.inpharm.com/news/166802/digital-pharma-social-media-twitter-abpi-code</link>
    <dc:creator>Herbelizer</dc:creator><dc:subject>SocialMedia Pharmaindustrie Twitter</dc:subject>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:5197a7564958/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Twitter"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.facebookbiz.de/artikel/pharmakonzerne-fluchten-vor-geoffneten-facebook-pinnwanden">
    <title>Pharmakonzerne flüchten vor geöffneten Facebook Pinnwänden</title>
    <dc:date>2011-08-21T12:02:35+00:00</dc:date>
    <link>http://www.facebookbiz.de/artikel/pharmakonzerne-fluchten-vor-geoffneten-facebook-pinnwanden</link>
    <dc:creator>Herbelizer</dc:creator><dc:subject>SocialMedia Facebook Pharmaindustrie Unternehmenskommunikation</dc:subject>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:fb81ebb7b778/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:SocialMedia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Facebook"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Unternehmenskommunikation"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Novartis-Kundenfang-mit-fiktiven-Biografien-/story/12484176">
    <title>Novartis: Kundenfang mit fiktiven Biografien - News Wirtschaft: Unternehmen - tagesanzeiger.ch</title>
    <dc:date>2010-10-19T22:29:15+00:00</dc:date>
    <link>http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Novartis-Kundenfang-mit-fiktiven-Biografien-/story/12484176</link>
    <dc:creator>Herbelizer</dc:creator><description><![CDATA["Die deutschen Journalisten Caroline Walter und Alexander Kobylinski sind im Zuge der Recherchen für ihr Buch «Patient im Visier» auf zahlreiche Blogs und Websites in Deutschland gestossen, die von der Pharmaindustrie betrieben werden – ohne dies offen zu deklarieren. "
]]></description>
<dc:subject>PR Blogs Astroturfing Pharmaindustrie Novartis</dc:subject>
<dc:identifier>https://pinboard.in/u:Herbelizer/b:93eb3666f5f1/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:PR"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Blogs"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Astroturfing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Pharmaindustrie"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Herbelizer/t:Novartis"/>
</rdf:Bag></taxo:topics>
</item>
</rdf:RDF>